Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT (2009) Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. FEBS J 276:13–26

Arnson Y, Shoenfeld Y, Amital H (2009) Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity 42:553–560

Arumugam TV, Tang S-C, Lathia JD, Cheng A, Mughal MR, Chigurupati S, et al (2007) Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci USA 104(35):14104–14109.

Arumugam TV, Selvaraj PK, Woodruff TM, Mattson MP (2008) Targeting ischemic brain injury with intravenous immunoglobulin. Expert Opin Ther Targets 12(1):19–29

Aschermann S, Lux A, Baerenwaldt A, Biburger M, Nimmerjahn F (2010) The other side of immunoglobulin G: Suppressor of inflammation. Clin Exp Immunol 160(2):161–167

Ashmarin IP, Nezavibatko VN, Levitskaya NG, Koshelev VB, Kamensky AA 1995 Design and investigation of an ACTH(4–10) analogue lacking d-amino acids and hydrophobic radicals. Neurosci Res Commun 16:105–112.

Asmarin IP, Nezavibat’ko VN, Miasoedov NF, Kamenskiĭ AA, Grivennikov IA, Ponomareva-Stepnaia MA, Andreeva LA, Kaplan AIa, Koshelev VB, Riasina TV (1997) A nootropic adrenocorticotropin analog 4–10-semax (l5 years experience in its design and study). Zh Vyssh Nerv Deiat I P Pavlova 47(3):420–430

Bashkatova VG, Koshelev VB, Fadyukova OE, Alexeev AA, Vanin AF, Rayevsky KS et al (2001) Novel synthetic analogue of ACTH 4–10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia. Brain Res 894(1):145–149

Bourdeau A, Dubé N, Tremblay ML (2005) Cytoplasmic protein tyrosine phosphatases, regulation and function: the roles of PTP1B and TC-PTP. Curr Opin Cell Biol 17(2):203–209

Chang L-Y, Lin Y-C, Mahalingam J, Huang C-T, Chen T-W, Kang C-W et al (2012) Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells. Cancer Res 72(5):1092–1102

Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD (1986) A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke 17(4):738–743

Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem 162(1):156–159

De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P et al (2008) Activation of natural regulatory T cells by IgG Fc-derived peptide “Tregitopes”. Blood 112(8):3303–3311

de Oliveira CEC, Oda JMM, LosiGuembarovski R, de Oliveira KB, Ariza CB, Neto JS et al (2014) CC chemokine receptor 5: the interface of host immunity and cancer. Dis Mark 2014:126954

de Wied D (1997) Neuropeptides in learning and memory processes. Behav Brain Res 83(1–2):83–90

Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A, Garrido C (2006) Heat shock proteins: endogenous modulators of apoptotic cell death. Handb Exp Pharmacol 172:171–198

Dmitrieva VG, Dergunova LV, Povarova OV, Skvortsova VI, Limborskaya SA, Myasoedov NF (2008a) The effect of semax and the PGP on expression of growth factor genes and receptors in rats. Dokl Biochem Biophys 422:261–264

Dmitrieva VG, Torshina EV, Yuzhakov VV, Povarova OV, Skvortsova VI, Limborska SA et al (2008b) Expression of sphingomyelin synthase 1 gene in rat brain focal ischemia. Brain Res 1188:222–227

Dmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV (2010) Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol 30(1):71–79

Dolotov OV, Zolotarev IA, Dorokhova EM, Andreeva LA, Alfeeva LI, Grivennikov IA et al (2004) The binding of Semax, ACTH 4–10 heptapeptide, to plasma membranes of the rat forebrain basal nuclei and its biodegradation. Bioorg Khim 30(3):241–246

Eibl MM, Wedgwood RJ (1989) Intravenous immunoglobulin: a review. Immunodefic Rev 1(Suppl):1–42.

Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G et al (2008) Expansion of CD4+ CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood 111(2):715–722

Fann DY-W, Lee SY, Manzanero S, Tang SC, Gelderblom M, Chunduri P et al (2013) Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 4:e790

Figueiredo HF, Bruestle A, Bodie B, Dolgas CM, Herman JP (2003) The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. Eur J Neurosci 18(8):2357–2364

Gesuete R, Packard AEB, Vartanian KB, Conrad VK, Stevens SL, Bahjat FR et al (2012) Poly-ICLC preconditioning protects the blood-brain barrier against ischemic injury in vitro through type I interferon signaling. J Neurochem 123(Suppl 2):75–85

Grigorjeva ME, Lyapina LA (2010) Anticoagulation and antiplatelet effects of semax under conditions of acute and chronic immobilization stress. Bull Exp Biol Med 149(1):44–46

Gusev EI, Skvortsova VI (2001) Brain ischaemia, 1st edn. Meditsina Publishers, Moscow

Hong H, Kim C-J, Kim J-D, Seo J-H (2014) β-glucan reduces exercise-induced stress through downregulation of c-Fos and c-Jun expression in the brains of exhausted rats. Mol Med Rep 9(5):1660–1666.

Howard J (2008) The IRG proteins: A function in search of a mechanism. Immunobiology 213(3–4):367–375

Kalaria RN, Ballard C (2001) Stroke and cognition. Curr Atheroscler Rep 3(4):334–339

Kaplan AI, Koshelev VB, Nezavibat’ko VN, Ashmarin IP (1992) Increased resistance to hypoxia effected by the neuropeptide preparation SEMAX. Fiziol Cheloveka 18(5):104–107

Kaplan AY, Kochetova AG, Nezavibatko VN, Rjasina TV, Ashmarin IP (1996) Synthetic ACTH analogue semax displays nootropic-like activity in human. Neurosci Res Commun 19(2):115–123.

Khorooshi R, Owens T (2010) Injury-induced type I IFN signaling regulates inflammatory responses in the central nervous system. J Immunol 185(2):1258–1264

Lai L-W, Yong K-C, Lien Y-HH (2012) Pharmacologic recruitment of regulatory T cells as a therapy for ischemic acute kidney injury. Kidney Int 81(10):983–992

Liu H, Xin L, Chan BPL, Teoh R, Tang BL, Tan YH (2002) Interferon-beta administration confers a beneficial outcome in a rabbit model of thromboembolic cerebral ischemia. Neurosci Lett 327(2):146–148

Liu S, Levine S, Winn H (2010) Targeting ischemic penumbra Part I: from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med 3(1):47–55

Maier CM, Yu F, Nishi T, Lathrop SJ, Chan PH (2006) Interferon-beta fails to protect in a model of transient focal stroke. Stroke 37(4):1116–1119

Martynova KV, Andreeva LA, Klimova PA, Kirillova IG, Shevchenko VP, Nagaev II et al (2009) Structural-functional study of glycine-and-proline-containing peptides (glyprolines) as potential neuroprotectors. Bioorg Khim 35(2):165–171

Medvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, Skvortsova VI, Myasoedov NF et al (2014) The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics 15:228

Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A et al (2001) Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 107(4):664–670

Mirabelli-Badenier M, Braunersreuther V, Viviani GL, Dallegri F, Quercioli A, Veneselli E et al (2011) CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. Thromb Haemost 105(3):409–420

O’Reilly AM, Currie RW, Clarke DB (2010) HspB1 (Hsp 27) expression and neuroprotection in the retina. Mol Neurobiol 42(2):124–132

Ogata S, Ogata A, Schneider-Schaulies S, Schneider-Schaulies S, Schneider-Schaulies J (2004) Expression of the interferon-alpha/beta-inducible MxA protein in brain lesions of subacute sclerosingpanencephalitis. J Neurol Sci 223(2):113–119

Pachner AR, Bertolotto A, Deisenhammer F (2003) Measurement of MxA mRNA or protein as a biomarker of IFN beta bioactivity: detection of antibody-mediated decreased bioactivity (ADB). Neurology 61(9 Suppl 5):S24–S26

Pfaffl MW, Horgan GW, Dempfle L (2002) Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30(9):e36

Polunin GS, Nurieva SM, Baiandin DL, Sheremet NL, Andreeva LA (2000) Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease. Vestn Oftalmol 116(1):15–18.

Saebøe-Larssen S, Lyamouri M, Merriam J, Oksvold MP, Lambertsson A (1998) Ribosomal protein insufficiency and the minute syndrome in Drosophila: a dose–response relationship. Genetics 148(3):1215–1224

Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M (1996) Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 35(11):3362–3367

Schwab I, Nimmerjahn F (2013) Intravenous immunoglobulin therapy: how does IgG modulate the immune system? Nat Rev Immunol 13(3):176–189

Shoji H, Mizoguchi K (2013) Brain region-specific reduction in c-Fos expression associated with an anxiolytic effect of yokukansan in rats. J Ethnopharmacol 149(1):93–102

Silva M, Aguiar DC, Diniz CRA, Guimarães FS, Joca SRL (2012) Neuronal NOS inhibitor and conventional antidepressant drugs attenuate stress-induced fos expression in overlapping brain regions. Cell Mol Neurobiol 32(3):443–453.

Simoncic PD, Lee-Loy A, Barber DL, Tremblay ML, McGlade CJ (2002) The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3. Curr Biol 12(6):446–453.

Sorce S, Bonnefont J, Julien S, Marq-Lin N, Rodriguez I, Dubois-Dauphin M et al (2010) Increased brain damage after ischaemic stroke in mice lacking the chemokine receptor CCR5. Br J Pharmacol 160(2):311–321

Stavchansky VV, Yuzhakov VV, Botsina AY, Skvortsova VI, Bondurko LN, Tsyganova MG et al (2011) The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. J Mol Neurosci 45(2):177–185

Storozhevykh TP, Tukhbatova GR, Senilova YE, Pinelis VG, Andreeva LA, Myasoyedov NF (2007) Effects of semax and its Pro-Gly-Pro fragment on calcium homeostasis of neurons and their survival under conditions of glutamate toxicity. Bull Exp Biol Med 143(5):601–604

Terao S, Yilmaz G, Stokes KY, Russell J, Ishikawa M, Kawase T et al (2008) Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation, and tissue injury after focal ischemia-reperfusion. Stroke 39(9):2560–2570

Thompson WL, Van Eldik LJ (2009) Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-3 through NFkB and MAPK dependent pathways in rat astrocytes [corrected]. Brain Res 1287:47–57.

Astrup J, Siesjo BK, Symon L (1981) Thresholds in cerebral ischemia—the ischemic penumbra. Stroke 12(6):723–725

Tschochner H, Hurt E (2003) Pre-ribosomes on the road from the nucleolus to the cytoplasm. Trends Cell Biol 13(5):255–263

Tunik S, Aluclu MU, Acar A, Akkoc H, Guzel A, Alabalik U et al (2016) The effects of intravenous immunoglobulin on cerebral ischemia in rats: an experimental study. Toxicol Ind Health 32(2):229–234

Ubogu EE, Callahan MK, Tucky BH, Ransohoff RM (2006) CCR5 expression on monocytes and T cells: modulation by transmigration across the blood-brain barrier in vitro. Cell Immunol 243(1):19–29

Uguccioni M, D’Apuzzo M, Loetscher M, Dewald B, Baggiolini M (1995) Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes. Eur J Immunol 25(1):64–68

Vasquez K, Sigrist K, Kucherlapati R, Demant P, Dietrich WF, Agoulnik S et al (2005) IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434(7072):772–777

Veldhuis WB, Floris S, van der Meide PH, Vos IMP, de Vries HE, Dijkstra CD et al (2003) Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood–brain barrier disruption. J Cereb Blood Flow Metab 23(9):1060–1069

Wen X, Kudo T, Payne L, Wang X, Rodgers L, Suzuki Y (2010) Predominant interferon-γ-mediated expression of CXCL9, CXCL10, and CCL5 proteins in the brain during chronic infection with Toxoplasma gondii in BALB/c mice resistant to development of toxoplasmic encephalitis. J Interferon Cytokine Res 30(9):653–660

Widiapradja A, Vegh V, Lok KZ, Manzanero S, Thundyil J, Gelderblom M et al (2012) Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways. J Neurochem 122(2):321–332